The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 24, 2015

Filed:

Feb. 28, 2013
Applicant:

Cardiac Pacemakers, Inc., St. Paul, MN (US);

Inventors:

Doug M. Birkholz, Shoreview, MN (US);

Douglas J. Brandner, New Brighton, MN (US);

Douglas J. Gifford, Ham Lake, MN (US);

David J. Ternes, Roseville, MN (US);

William J. Linder, Golden Valley, MN (US);

Assignee:

Cardiac Pacemakers, Inc., St. Paul, MN (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61N 1/37 (2006.01); A61N 1/36 (2006.01);
U.S. Cl.
CPC ...
A61N 1/36125 (2013.01); A61N 1/3605 (2013.01); A61N 1/36082 (2013.01); A61N 1/36178 (2013.01); A61N 1/36142 (2013.01);
Abstract

Various implantable device embodiments may comprise a neural stimulator configured to deliver a neurostimulation therapy with stimulation ON times and stimulation OFF times where a dose of the neurostimulation therapy is provided by a number of neurostimulation pulses over a period of time. The neural stimulator may be configured to monitor the dose of the delivered neurostimulation therapy against dosing parameters. The neural stimulator may be configured to declare a fault if the monitored dose does not favorably compare to a desired dose for the neurostimulation therapy, or may be configured to record data for the monitored dose of the delivered neurostimulation therapy, or may be configured to both record data for the monitored dose of the delivered neurostimulation therapy and declare a fault if the monitored dose does not favorably compare to a desired dose for the neurostimulation therapy.


Find Patent Forward Citations

Loading…